Skip to main content
. 2015 Jul 14;29(4):275–284. doi: 10.1007/s40259-015-0132-7

Fig 4.

Fig 4

Prescribing patterns of biosimilar erythropoiesis-stimulating agent (ESA) users, stratified by calendar year and center. “Naive” means no ESA dispensing within the previous year, “Prevalent” means only the same biosimilar dispensing within the previous year, and “Switcher” means at least one dispensing of a different ESA within the previous year. The numbers shown inside each bar represent the numbers of naive, prevalent, and switcher users. 1 year of database history before each year in the graph should be available, so it was not possible to evaluate use in the year 2011 in the Palermo Local Health Unit (LHU)